Stereotaxis Inc. (
NYSEAMERICAN:STXS -
Get Free Report)'s share price was up 3.7% during trading on Monday . The stock traded as high as $3.13 and last traded at $3.10. Approximately 338,622 shares were traded during trading, a decline of 42% from the average daily volume of 582,539 shares. The stock had previously closed at $2.99.
Stereotaxis Trading Up 3.7%
The firm's fifty day moving average price is $2.93 and its 200 day moving average price is $2.40. The firm has a market capitalization of $282.32 million, a PE ratio of -10.69 and a beta of 1.65.
Hedge Funds Weigh In On Stereotaxis
Several institutional investors and hedge funds have recently modified their holdings of STXS. Warberg Asset Management LLC grew its holdings in shares of Stereotaxis by 260.1% during the 2nd quarter. Warberg Asset Management LLC now owns 1,201,500 shares of the company's stock valued at $2,547,000 after acquiring an additional 867,878 shares in the last quarter. Prescott Group Capital Management L.L.C. grew its holdings in shares of Stereotaxis by 44.5% during the 2nd quarter. Prescott Group Capital Management L.L.C. now owns 1,139,252 shares of the company's stock valued at $2,415,000 after acquiring an additional 350,600 shares in the last quarter. Essex Investment Management Co. LLC grew its holdings in shares of Stereotaxis by 28.3% during the 1st quarter. Essex Investment Management Co. LLC now owns 1,556,094 shares of the company's stock valued at $2,739,000 after acquiring an additional 343,130 shares in the last quarter. Rhumbline Advisers increased its position in Stereotaxis by 223.7% during the second quarter. Rhumbline Advisers now owns 148,913 shares of the company's stock worth $316,000 after buying an additional 102,916 shares during the last quarter. Finally, Legato Capital Management LLC boosted its stake in shares of Stereotaxis by 28.1% during the 1st quarter. Legato Capital Management LLC now owns 461,427 shares of the company's stock worth $812,000 after acquiring an additional 101,136 shares in the last quarter. 45.35% of the stock is currently owned by hedge funds and other institutional investors.
Stereotaxis Company Profile
(
Get Free Report)
Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Stereotaxis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stereotaxis wasn't on the list.
While Stereotaxis currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
